Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrobulbar Injection of Autoserum in the Treatment of Retinitis Pigmentosa: A Prospective, Non-randomized Interventional Study

NCT03998384 is registered in ClinicalTrials.gov with Aier School of Ophthalmology, Central South University as lead sponsor.

NCT NCT03998384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03998384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrobulbar Injection of Autoserum in the Treatment of Retinitis Pigmentosa: A Prospective, Non-randomized Interventional Study
Lead sponsor
Aier School of Ophthalmology, Central South University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 31, 2022
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa